AkzoNobel also held its Extraordinary General Meeting today, where AkzoNobel shareholders voted to approve the Merger. Each of AkzoNobel and Axalta will also file other relevant documents in connection with the proposed transaction. Forward-looking statements are based upon current plans, estimates and expectations that are subject to risks, uncertainties and assumptions. These risks, as well as other risks associated with the proposed transaction, are more fully discussed in the proxy statement/prospectus. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements.